These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 29965778)

  • 1. Application of metabolomics to preeclampsia diagnosis.
    Nobakht M Gh BF
    Syst Biol Reprod Med; 2018 Oct; 64(5):324-339. PubMed ID: 29965778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomics and first-trimester prediction of early-onset preeclampsia.
    Bahado-Singh RO; Akolekar R; Mandal R; Dong E; Xia J; Kruger M; Wishart DS; Nicolaides K
    J Matern Fetal Neonatal Med; 2012 Oct; 25(10):1840-7. PubMed ID: 22494326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30-34 weeks' gestation.
    Tsiakkas A; Saiid Y; Wright A; Wright D; Nicolaides KH
    Am J Obstet Gynecol; 2016 Jul; 215(1):87.e1-87.e17. PubMed ID: 26875953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19-24 weeks' gestation.
    Gallo DM; Wright D; Casanova C; Campanero M; Nicolaides KH
    Am J Obstet Gynecol; 2016 May; 214(5):619.e1-619.e17. PubMed ID: 26627730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-Trimester Serum Acylcarnitine Levels to Predict Preeclampsia: A Metabolomics Approach.
    Koster MP; Vreeken RJ; Harms AC; Dane AD; Kuc S; Schielen PC; Hankemeier T; Berger R; Visser GH; Pennings JL
    Dis Markers; 2015; 2015():857108. PubMed ID: 26146448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Added value of angiogenic factors for the prediction of early and late preeclampsia in the first trimester of pregnancy.
    Crovetto F; Figueras F; Triunfo S; Crispi F; Rodriguez-Sureda V; Peguero A; Dominguez C; Gratacos E
    Fetal Diagn Ther; 2014; 35(4):258-66. PubMed ID: 24714555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of metabolomic models for prediction of early-onset preeclampsia.
    Bahado-Singh RO; Syngelaki A; Akolekar R; Mandal R; Bjondahl TC; Han B; Dong E; Bauer S; Alpay-Savasan Z; Graham S; Turkoglu O; Wishart DS; Nicolaides KH
    Am J Obstet Gynecol; 2015 Oct; 213(4):530.e1-530.e10. PubMed ID: 26116099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
    Noori M; Donald AE; Angelakopoulou A; Hingorani AD; Williams DJ
    Circulation; 2010 Aug; 122(5):478-87. PubMed ID: 20644016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia].
    Gao J; Shen J; Jiang Y; Zhou X; Qi H; Liu X; Liu J; Yang J; Bian X
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jan; 49(1):22-5. PubMed ID: 24694913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of first-trimester angiogenic factors with placental histological findings in late-onset preeclampsia.
    Triunfo S; Crovetto F; Crispi F; Rodriguez-Sureda V; Dominguez C; Nadal A; Peguero A; Gratacos E; Figueras F
    Placenta; 2016 Jun; 42():44-50. PubMed ID: 27238713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study.
    Rizos D; Eleftheriades M; Karampas G; Rizou M; Haliassos A; Hassiakos D; Vitoratos N
    Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):225-30. PubMed ID: 24035323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application of the concetrations ratio of soluble receptor tyrosine kinase type 1, and placental growth factor for short-term prediction and diagnosis of preeclampsia].
    Bubeníková Š; Cíchová A; Roubalová L; Durdová V; Vlk R
    Ceska Gynekol; 2016; 81(4):272-278. PubMed ID: 27882748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MoM cutoffs for variables, an important tool for multivariate analysis and accurate interpretation of preeclampsia risk in high-risk pregnancy at 11-13
    Verma J; Thomas DC; Jhingan G; Puri RD; Verma IC
    Hypertens Pregnancy; 2016 Nov; 35(4):548-558. PubMed ID: 27599037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First Trimester Urine and Serum Metabolomics for Prediction of Preeclampsia and Gestational Hypertension: A Prospective Screening Study.
    Austdal M; Tangerås LH; Skråstad RB; Salvesen K; Austgulen R; Iversen AC; Bathen TF
    Int J Mol Sci; 2015 Sep; 16(9):21520-38. PubMed ID: 26370975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of serum and urinary soluble sFlt-1 and PLGF in the diagnosis of preeclampsia.
    Tang P; Xu J; Xie BJ; Wang QM
    Hypertens Pregnancy; 2017 Feb; 36(1):48-52. PubMed ID: 27834501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarker identification and pathway analysis of preeclampsia based on serum metabolomics.
    Chen T; He P; Tan Y; Xu D
    Biochem Biophys Res Commun; 2017 Mar; 485(1):119-125. PubMed ID: 28188789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of preeclampsia in primigravida in late first trimester using serum placental growth factor alone and by combination model.
    Agarwal R; Chaudhary S; Kar R; Radhakrishnan G; Tandon A
    J Obstet Gynaecol; 2017 Oct; 37(7):877-882. PubMed ID: 28569565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential plasma angiogenic factors levels in women with suspected preeclampsia.
    Baltajian K; Bajracharya S; Salahuddin S; Berg AH; Geahchan C; Wenger JB; Thadhani R; Karumanchi SA; Rana S
    Am J Obstet Gynecol; 2016 Jul; 215(1):89.e1-89.e10. PubMed ID: 26827880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis.
    Frampton GK; Jones J; Rose M; Payne L
    Health Technol Assess; 2016 Nov; 20(87):1-160. PubMed ID: 27918253
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.